您当前所在位置:首页 > 材料科学 > 新品上市
序号 标题 次数 作者 发布时间
89866 DOTA-GA,螯合剂DOTA肽缀合物 172 wyh 2024-12-03
89867 DOTA共轭二膦酸盐,DOTA-HBP 170 wyh 2024-12-03
89868 DOTA-神经介素n ,DOTA-Neuromedin N 156 wyh 2024-12-03
89869 tris-烯丙基-DOTA , tris-allyl-DOTA 153 wyh 2024-12-03
89870 6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine 160 WYQ 2024-12-03
89871 6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine 178 WYQ 2024-12-03
89872 cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA 137 wyh 2024-12-03
89873 6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine 161 WYQ 2024-12-03
89874 MMA-DOTA-Cys 61 ,DOTA-马来酰亚胺-半胱氨酸 192 wyh 2024-12-03
89875 DOTA-BR96 ,DOTA标记BR96单克隆抗体 174 wyh 2024-12-03
89876 DOTA-ggNle-cycmsh(hex),内酰胺桥环化肽偶联DOTA 167 wyh 2024-12-03
89877 DOTA-sCCK8[Phe2(p-CH2SO3H) ,大环DOTA偶联多肽 168 wyh 2024-12-03
89878 3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪(BTATz);3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)- 1,2,4,5-tetrazine 162 WYQ 2024-12-03
89879 3,3'-偶氮二(6-氨基-1,2,4,5-四嗪)(DAAT);3,3'-azobis(6-amino-1,2,4,5-tetrazine) 333 WYQ 2024-12-03
89880 c(DOTA-RGDf),大环螯合剂DOTA环化RGD肽序列 185 wyh 2024-12-03
89881 3,6-双(吡啶-3-基)-1,2,4,5-四嗪(3,3'-吡喃);3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) 176 WYQ 2024-12-03
89882 3,6-双(2-甲氧基苯基)-1,2-二氢-1,2,4,5-四嗪(2-MDHT);3,6-bis(2-methoxyphenyl)-1,2-dihydro-1,2,4,5-tetrazine 183 WYQ 2024-12-03
89883 3,6-二甲基-1,2,4,5-四嗪;3,6-Dimethyl-1,2,4,5-tetrazine 189 WYQ 2024-12-03
89884 3,3'-偶氮(6-氨基-1,2,4,5-四嗪);3,3'-Azobis(6-amino-1,2,4,5-tetrazine)(DAAT) 214 WYQ 2024-12-03
89885 3,6-d二肼基-1,2,4,5-四嗪(DHT) 167 WYQ 2024-12-03
89886 DOTA-D-phe1-Tyr3-奥曲肽 ,Ga-68-DOTA-TATE 144 wyh 2024-12-03
89887 DOTA-cCCK,DOTA偶联胆囊收缩素(CCK)受体 279 wyh 2024-12-03
89888 3,6-d氨基-1,2,4,5-四嗪(DATZ) 182 WYQ 2024-12-03
89889 3-d氨基-6-(3,5-二甲基乙基吡唑-1-基)-1,2,4,5-四嗪(ADMPT) 220 WYQ 2024-12-03
89890 [DOTA]LTT-SS28 ,生长抑素模拟物 213 wyh 2024-12-03
89891 DOTA-minigastrin (CP04) , DOTA-小胃泌素(CP04) 252 wyh 2024-12-03
89892 DOTA-rhuEpo ; DOTA-酰肼偶联rhuEpo 140 wyh 2024-12-03
89893 1,2,4,5-四嗪 , 化学式:C2H2N4 263 WYQ 2024-12-03
89894 DOTA-Benerotide ;靶向生长抑素受体 148 wyh 2024-12-03
89895 1,2,4,5-Tetrazines by Palladium Catalysis(钯催化1,2,4,5-四嗪的合成) 145 WYQ 2024-12-03
89896 5-苯基-1,2,4-三嗪-3-胺为例,为C9H8N4 151 WYQ 2024-12-03
89897 DOTA-PEG-LA-AuNP,DOTA-PEG-硫辛酸修饰纳米金纳米粒子 195 wyh 2024-12-03
89898 3,6-二(吡啶-2-基)-1,2,4,5-四嗪(pytz) 212 WYQ 2024-12-03
89899 HYNIC-PEG11-Tz;联肼尼克酰胺-十一聚乙二醇-四嗪;HYNIC-PEG11-Tetrazine 199 WYQ 2024-12-03
89900 DOTA-NT肽偶联金纳米粒子 ,DOTA-NT-AuNPs 154 wyh 2024-12-03
89901 [Zr-89]Zr-DFO-PEG5-Tz;[Zr-89]Zr-DFO-PEG5-Tetrazine 200 WYQ 2024-12-03
89902 MeTz-NOTA-RGD;甲基四嗪-大环配体-多肽 208 WYQ 2024-12-03
89903 DOTA-Tyr(3)-奥曲肽, DOTA-Tyr(3)-Octreotide 142 wyh 2024-12-03
89904 AgNPs–pytz(3,6-二(吡啶-2-基)-1,2,4,5-四嗪包覆的银纳米粒子) 157 WYQ 2024-12-03
89905 3,6-di(pyridin-2-yl)-1,2,4,5-s-tetrazine (pytz,3,6-二(吡啶-2-基)-1,4-二氢-1,2,4,5-四嗪) 170 WYQ 2024-12-03
89906 DOTA-叶酸偶联物,DOTA-Folate 180 wyh 2024-12-03
89907 CQDs-DOTA-Yb,镱-DOTA螯合物功能化碳量子点 164 wyh 2024-12-03
89908 3,6-dihydrazino-s-tetrazine (DHT,3,6-二肼基-s-四嗪) 167 WYQ 2024-12-03
89909 BCN-PEG-PAMAM ,环丙烷环辛炔-聚乙二醇-聚酰胺 207 zyl 2024-12-03
89910 (DNAZTzDMP)2Ni(H2O)2][NO3]2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 158 WYQ 2024-12-03
库存查询